HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression.

Abstract
How tumor cells genetically lose antigenicity and evade immune checkpoints remains largely elusive. We report that tissue-specific expression of the human long noncoding RNA LINK-A in mouse mammary glands initiates metastatic mammary gland tumors, which phenotypically resemble human triple-negative breast cancer (TNBC). LINK-A expression facilitated crosstalk between phosphatidylinositol-(3,4,5)-trisphosphate and inhibitory G-protein-coupled receptor (GPCR) pathways, attenuating protein kinase A-mediated phosphorylation of the E3 ubiquitin ligase TRIM71. Consequently, LINK-A expression enhanced K48-polyubiquitination-mediated degradation of the antigen peptide-loading complex (PLC) and intrinsic tumor suppressors Rb and p53. Treatment with LINK-A locked nucleic acids or GPCR antagonists stabilized the PLC components, Rb and p53, and sensitized mammary gland tumors to immune checkpoint blockers. Patients with programmed ccll death protein-1(PD-1) blockade-resistant TNBC exhibited elevated LINK-A levels and downregulated PLC components. Hence we demonstrate lncRNA-dependent downregulation of antigenicity and intrinsic tumor suppression, which provides the basis for developing combinational immunotherapy treatment regimens and early TNBC prevention.
AuthorsQingsong Hu, Youqiong Ye, Li-Chuan Chan, Yajuan Li, Ke Liang, Aifu Lin, Sergey D Egranov, Yaohua Zhang, Weiya Xia, Jing Gong, Yinghong Pan, Sujash S Chatterjee, Jun Yao, Kurt W Evans, Tina K Nguyen, Peter K Park, Jiewei Liu, Cristian Coarfa, Sri Ramya Donepudi, Vasanta Putluri, Nagireddy Putluri, Arun Sreekumar, Chandrashekar R Ambati, David H Hawke, Jeffrey R Marks, Preethi H Gunaratne, Abigail S Caudle, Aysegul A Sahin, Gabriel N Hortobagyi, Funda Meric-Bernstam, Lieping Chen, Dihua Yu, Mien-Chie Hung, Michael A Curran, Leng Han, Chunru Lin, Liuqing Yang
JournalNature immunology (Nat Immunol) Vol. 20 Issue 7 Pg. 835-851 (07 2019) ISSN: 1529-2916 [Electronic] United States
PMID31160797 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • LINK-A long non-coding RNA, human
  • RNA, Long Noncoding
  • Receptors, G-Protein-Coupled
  • Tumor Suppressor Protein p53
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Adenoma (genetics, metabolism)
  • Animals
  • Antigen Presentation (immunology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Transformation, Neoplastic (genetics, metabolism)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Disease Models, Animal
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • Neoplasms (genetics, immunology, metabolism, pathology)
  • Oncogenes
  • Phosphorylation
  • RNA, Long Noncoding (genetics)
  • Receptors, G-Protein-Coupled (antagonists & inhibitors)
  • Tumor Escape (genetics, immunology)
  • Tumor Microenvironment (genetics, immunology)
  • Tumor Suppressor Protein p53 (metabolism)
  • Ubiquitination
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: